Clinical observation of bevacizumab(avastin)for treating age-related macular degeneration

Clinical observation of bevacizumab(avastin)for treating age-related macular degeneration

AIM: To evaluate the safety and efficacy of intravitreal bevacizumab(avastin)injection in patients with exudative age related macular degeneration(AMD). <p>METHODS: The records of patients treated with intravitreal injection of 1.75mg bevacizumab for AMD were retrospectively reviewed. All pati...

Full description

Bibliographic Details
Main Authors: Zhi-Guang Duan, Li-Yun Yu, Yun-Qin Jia, Ni Mo, Yin-Chao Chen, Tao Tao, Min Liu, Shi-Xue Pu, Ming-Zhi Li
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2014-06-01
Series:Guoji Yanke Zazhi
Subjects:
bevacizumab(avastin)
age-related macular degeneration
choroidal neovascularization
clinical observation
Online Access:http://www.ies.net.cn/cn_publish/2014/6/201406009.pdf

Internet

http://www.ies.net.cn/cn_publish/2014/6/201406009.pdf

Similar Items